BIOR
Biora Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
994,990
P/E Ratio
0.61
EPS
$0.36
Beta
1.28
52W High
$0.22
52W Low
$0.15
50-Day MA
$0.22
200-Day MA
$0.22
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biora Therapeutics Inc
Biora Therapeutics, Inc., a biotechnology company, is engaged in the development of oral biotherapeutic products. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 860,000 |
| Gross Profit (TTM) | $1.25M |
| EBITDA | $-67.51M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -125.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-36.43 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 0.74 |
| EV/Revenue | 41.98 |
| EV/EBITDA | -2.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 15800.00% |
| Shares Outstanding | $4.52M |
| Float | $2.52M |
| % Insiders | 0.10% |
| % Institutions | 36.00% |
Data last updated: 4/7/2026